• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Lind Global Fund Ii Lp sold $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) and bought $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) (SEC Form 4)

    9/28/23 4:30:24 PM ET
    $RWLK
    Industrial Specialties
    Health Care
    Get the next $RWLK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Lind Global Fund II LP

    (Last) (First) (Middle)
    444 MADISON AVENUE
    41ST FLOOR

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ReWalk Robotics Ltd. [ RWLK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    09/26/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Ordinary Shares, par value NIS 0.25 per share 09/26/2023 P 5,031,200 A $0.7 9,890,010 I See footnote(1)
    Ordinary Shares, par value NIS 0.25 per share 09/26/2023 S 5,031,200 D $0.7 0 I See footnote(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Lind Global Fund II LP

    (Last) (First) (Middle)
    444 MADISON AVENUE
    41ST FLOOR

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Lind Global Macro Fund LP

    (Last) (First) (Middle)
    444 MADISON AVE, FLOOR 41

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)
    Explanation of Responses:
    1. Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
    2. Reflects securities held directly by Lind Global Macro Fund LP. Lind Global Partners LLC, the general partner of Lind Global Macro Fund LP, and Jeff Easton, the managing member of Lind Global Partners LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
    Lind Global Fund II LP, by: Lind Global Partners II LLC, its General Partner, by: /s/ Jeff Easton, its Managing Member 09/28/2023
    Lind Global Macro Fund, LP by: Lind Global Partners LLC, its General Partner, by: /s/ Jeff Easton, its Managing Member 09/28/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RWLK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RWLK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RWLK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • VA STAND Act introduced in the United States Senate

      MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today applauded the introduction of a Senate companion bill to H.R. 6373, the VA Spinal Trauma Access to New Devices (STAND) Act. The Senate companion bill was introduced by Chairman of the Senate Veterans' Affairs Committee, Senator Jon Tester (D-MT), and the Ranking Member of that committee, Senator Jerry Moran (R-KS).

      3/22/24 8:30:00 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care
    • Lifeward Announces Reverse Share Split

      Reverse split initiated to regain compliance with Nasdaq listing requirements Financial guidance for 2024 and profitability target for 2026 on existing capital remain unchanged MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that effective with the open of the market on Friday, March 15, 2024, the Company will complete a 1-for-7 reverse

      3/13/24 11:45:17 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care
    • ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

      Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy. Additional study demonstrates that the improvements in walking speed and distance following high-intensity gait training with the ReStore Exo-Suit were maintained by individuals post-stroke 4 weeks after the intervention had concluded. Combined results highlight the clinical value of the ReStore Exo-Suit and its related breakthrough propulsion-augmenting technologies within the Lifeward product development pipeline. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, M

      3/8/24 8:30:00 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lind Global Fund Ii Lp bought $40,089 worth of Ordinary Shares (54,917 units at $0.73) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/21/23 4:37:18 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp bought $49,516 worth of Ordinary Shares (72,818 units at $0.68) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/16/23 4:37:44 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp sold $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) and bought $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      9/28/23 4:30:24 PM ET
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lind Global Fund Ii Lp bought $40,089 worth of Ordinary Shares (54,917 units at $0.73) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/21/23 4:37:18 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp bought $49,516 worth of Ordinary Shares (72,818 units at $0.68) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/16/23 4:37:44 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp sold $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) and bought $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      9/28/23 4:30:24 PM ET
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright reiterated coverage on ReWalk Robotics with a new price target

      HC Wainwright reiterated coverage of ReWalk Robotics with a rating of Buy and set a new price target of $3.50 from $2.50 previously

      3/8/21 8:24:25 AM ET
      $RWLK
      Industrial Specialties
      Health Care
    • HC Wainwright & Co. reiterated coverage on ReWalk Robotics with a new price target

      HC Wainwright & Co. reiterated coverage of ReWalk Robotics with a rating of Buy and set a new price target of $3.50 from $2.50 previously

      3/1/21 7:05:13 AM ET
      $RWLK
      Industrial Specialties
      Health Care